What do these four countries have in common? At least two things.
-
Which vaccine are they using?
Edit:
Interesting…questions on effectiveness in UAE and Bahrain. Officially 79% effective but maybe 60% and now a third shot?
-
@loki said in What do these four countries have in common? At least two things.:
Which vaccine are they using?
Winner!
The Persian Gulf island nation of Bahrain, battling a sharp resurgence of Covid-19 despite high levels of inoculation with a Chinese-made vaccine, has started giving booster shots to vulnerable citizens using a different vaccine made by Pfizer Inc. and BioNTech SE, a senior official said.
Waleed Khalifa al Manea, Bahrain’s undersecretary of health, said the vaccine manufactured by state-owned Chinese drugmaker Sinopharm, which has accounted for more than 60% of Bahrain’s inoculations so far, was providing a high degree of protection. More than 90% of people hospitalized in the current Covid-19 wave, the worst the country has faced, hadn’t been vaccinated, he said.
Still, Dr. al Manea added, Bahrain residents who are over 50, are obese or have chronic illnesses now are being urged to get another shot six months after their full Sinopharm vaccination—with the Pfizer-BioNTech vaccine. The government started offering the boosters at the end of May, he said.
Bahrain, which has made the Pfizer-BioNTech vaccine available to unvaccinated residents for months, will continue to offer the choice of Sinopharm to those who prefer the Chinese vaccine, Dr. al Manea said. The government’s BeAware app allows users to book a Sinopharm booster shot, but says that Pfizer-BioNTech is recommended for more-vulnerable population groups.
Sinopharm and other Chinese vaccines have become key tools of Beijing’s international diplomacy, especially in developing nations unable to secure sufficient doses of U.S. and European-made shots. Sinopharm and another shot, manufactured by Sinovac Biotech Ltd., have already received emergency approval from the World Health Organization.
The two vaccines are manufactured with inactivated virus, a long-used technique for making vaccines. The Pfizer-BioNTech shot relies on a new technology employing messenger RNA.
Published clinical data on Sinopharm’s efficiency among the population groups most vulnerable to severe disease is scant. The vaccine’s main clinical trial involved 40,382 participants in the Middle East, most of them in the United Arab Emirates.
The study’s peer-reviewed results, published on May 26 by the Journal of the American Medical Association, found 78% efficacy against symptomatic disease for one of two versions of the Sinopharm vaccine. However, the cohort was made up mostly of healthy young men—the participants’ mean age was 36—and the study reported only two cases of severe disease, a statistically insufficient amount, in the placebo group.
-
Interesting, and how many of the Chinese people have used this vaccine and what are the real numbers in China right now?
-
@lufins-dad said in What do these four countries have in common? At least two things.:
how many of the Chinese people have used this vaccine and what are the real numbers in China right now?
-
@copper said in What do these four countries have in common? At least two things.:
So China has decided that it is time for us to hate them.
Trump exposed China for its duplicity and now there are few doves in the US to defend them. China got very cocky but may feel now is the time to run the table anyway. Their last gift was the US media that sold the narrative that the Lab covid origin theory was a conspiracy theory.
The media literally walked from the potential cover up of the century.